Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.

about

Prasugrel hydrochloride for the treatment of sickle cell disease.

P2860

Q39340714-C1295EF7-8C5E-4015-A482-DEE50A59FB6C

P2860

Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.

Item

http://www.wikidata.org/entity/Q38974884

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.

@en

type

Item

label

Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.

@en

prefLabel

Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.

@en

P1476

Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.

@en

P2093

Alberto Valbusa

http://www.w3.org/2001/XMLSchema#string

Claudio Brunelli

http://www.w3.org/2001/XMLSchema#string

Daniele Bianco

http://www.w3.org/2001/XMLSchema#string

Francesco Chiarella

http://www.w3.org/2001/XMLSchema#string

Gian Marco Rosa

http://www.w3.org/2001/XMLSchema#string

Laura Massobrio

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective.

The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electroca

Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers.

P304

1491-1502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425255.2016.1244524

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27715344

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.

about

P2860

P2860

Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698